Literature DB >> 20801186

Preferential β-arrestin signalling at low receptor density revealed by functional characterization of the human FSH receptor A189 V mutation.

Thibaud Tranchant1, Guillaume Durand, Christophe Gauthier, Pascale Crépieux, Alfredo Ulloa-Aguirre, Dominique Royère, Eric Reiter.   

Abstract

The A189 V inactivating mutation of the human FSH receptor (FSHR) leads to subfertility in men and primary ovarian failure in women. This mutation has previously been associated with intracellular retention of the FSHR and impaired cAMP production. Here, we show that the A189 V FSHR stably expressed in HEK293N cells provoked ERK MAP kinases phosphorylation through β-arrestins, independently of the canonical cAMP/PKA pathway. Interesting, both the A189 V and wild-type (Wt) FSHRs selectively activated cAMP-independent ERK phosphorylation when expressed at low plasma membrane densities. These data indicate that the selective intracellular signalling triggered by the A189 V FSHR resulted from reduced membrane expression rather than by switching receptor coupling. Hence, receptor density at the plasma membrane might control the balance between distinct signal transduction mechanisms. Furthermore, our results help to clarify why mutations of FSHβ are more deleterious to human fertility than the FSHR A189 V mutation which preserves parts of receptor signalling repertoire.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20801186     DOI: 10.1016/j.mce.2010.08.016

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  34 in total

Review 1.  Pharmacoperones: a new therapeutic approach for diseases caused by misfolded G protein-coupled receptors.

Authors:  Alfredo Ulloa-Aguirre; P Michael Conn
Journal:  Recent Pat Endocr Metab Immune Drug Discov       Date:  2011-01

2.  mRNA-selective translation induced by FSH in primary Sertoli cells.

Authors:  Astrid Musnier; Kelly León; Julia Morales; Eric Reiter; Thomas Boulo; Vlad Costache; Patrick Vourc'h; Domitille Heitzler; Nathalie Oulhen; Anne Poupon; Sandrine Boulben; Patrick Cormier; Pascale Crépieux
Journal:  Mol Endocrinol       Date:  2012-03-01

Review 3.  Are circulating gonadotropin isoforms naturally occurring biased agonists? Basic and therapeutic implications.

Authors:  Brian J Arey; Francisco J López
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

Review 4.  Minireview: Spatial Programming of G Protein-Coupled Receptor Activity: Decoding Signaling in Health and Disease.

Authors:  Camilla West; Aylin C Hanyaloglu
Journal:  Mol Endocrinol       Date:  2015-06-29

Review 5.  Mutations in G protein-coupled receptors that impact receptor trafficking and reproductive function.

Authors:  Alfredo Ulloa-Aguirre; Teresa Zariñán; James A Dias; P Michael Conn
Journal:  Mol Cell Endocrinol       Date:  2013-06-24       Impact factor: 4.102

Review 6.  Receptors and signaling pathways involved in proliferation and differentiation of Sertoli cells.

Authors:  Thaís Fg Lucas; Aline R Nascimento; Raisa Pisolato; Maristela T Pimenta; Maria Fatima M Lazari; Catarina S Porto
Journal:  Spermatogenesis       Date:  2014-02-20

7.  Quantification of the brassinosteroid insensitive1 receptor in planta.

Authors:  G Wilma van Esse; Adrie H Westphal; Ramya Preethi Surendran; Catherine Albrecht; Boudewijn van Veen; Jan Willem Borst; Sacco C de Vries
Journal:  Plant Physiol       Date:  2011-05-26       Impact factor: 8.340

Review 8.  Pharmacological chaperones for misfolded gonadotropin-releasing hormone receptors.

Authors:  P Michael Conn; Alfredo Ulloa-Aguirre
Journal:  Adv Pharmacol       Date:  2011

9.  Trafficking of the follitropin receptor.

Authors:  Alfredo Ulloa-Aguirre; James A Dias; George Bousfield; Ilpo Huhtaniemi; Eric Reiter
Journal:  Methods Enzymol       Date:  2013       Impact factor: 1.600

Review 10.  Mechanistic insight into how gonadotropin hormone receptor complexes direct signaling†.

Authors:  Gillian P Johnson; Kim Carol Jonas
Journal:  Biol Reprod       Date:  2020-04-15       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.